Yuki Kishikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuki Kishikawa has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Yukie Kawahara
Department of Rehabilitation Sciences, Faculty of Rehabilitation Sciences, Nishikyushu University, Kanzaki, Japan
4 shared publications- Akinori Nishi
School of Medical Technology, Kurume University School of Medicine, Kurume, Japan
3 shared publications Hiroshi Kawahara
Department of Rehabilitation Sciences, Faculty of Rehabilitation Sciences, Nishikyushu University, Kanzaki, Japan
3 shared publicationsAkinori Nishi
Department of Pharmacology, Kurume University School of Medicine, Asahi-machi 67, Kurume, Fukuoka 830-0011, Japan
2 shared publicationsFumi Kaneko
Department of Pharmacology, Kurume University School of Medicine, Asahi-machi 67, Kurume, Fukuoka 830-0011, Japan
2 shared publications- Hiroshi Kawahara
Department of Dental Anesthesiology, School of Dental Medicine, Tsurumi University, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan
2 shared publications
Latest Publications
- 8 November 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1008, 178352
Ghrelin restores D1 receptor-mediated dopamine neurotransmission and enhances attentive behaviour in Mecp2 KO mice
- 8 November 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1008, 178352
Ghrelin restores D1 receptor-mediated dopamine neurotransmission and enhances attentive behaviour in Mecp2 KO mice
- Open Access
- 8 September 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 988178
Dysregulation of dopamine neurotransmission in the nucleus accumbens in immobilization-induced hypersensitivity
Cast immobilization causes sensory hypersensitivity, which is also a symptom of neuropathic pain and chronic pain. However, the mechanisms underlying immobilization-induced hypersensitivity remain unclear. The present study investigated the role of dopamine neurotransmission in the nucleus accumbens shell (NAcSh) of rats with cast immobilization-induced mechanical hypersensitivity using in vivo microdialysis. Cast immobilization of the hind limb decreased the paw withdrawal threshold (PWT). Mechanical stimulation of the cast-immobilized hind limb induced a decrease in dopamine in the NAcSh, and this decrease was associated with the upregulation of presynaptic D2-like receptors. A D2-like receptor antagonist infused into the NAcSh reversed the decrease in PWT in rats with cast immobilization, whereas a D2-like receptor agonist infused into the NAcSh induced a decrease in PWT in control rats. In addition, the expression of the D2 receptor (Drd2) mRNA in the NAcSh was increased by cast immobilization. Importantly, systemic administration of the D2-like receptor antagonist reversed the decrease in PWT in rats with cast immobilization. As dopamine levels regulated by presynaptic D2-like receptors did not correlate with the PWT, it is presumed that the D2-like receptor antagonist or agonist acts on postsynaptic D2-like receptors. These results suggest that immobilization-induced mechanical hypersensitivity is attributable to the upregulation of postsynaptic D2-like receptors in the NAc. Blockade of D2-like receptors in the NAcSh is a potential therapeutic strategy for immobilization-induced hypersensitivity.
- 8 September 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 988178
Open AccessDysregulation of dopamine neurotransmission in the nucleus accumbens in immobilization-induced hypersensitivity
Cast immobilization causes sensory hypersensitivity, which is also a symptom of neuropathic pain and chronic pain. However, the mechanisms underlying immobilization-induced hypersensitivity remain unclear. The present study investigated the role of dopamine neurotransmission in the nucleus accumbens shell (NAcSh) of rats with cast immobilization-induced mechanical hypersensitivity using in vivo microdialysis. Cast immobilization of the hind limb decreased the paw withdrawal threshold (PWT). Mechanical stimulation of the cast-immobilized hind limb induced a decrease in dopamine in the NAcSh, and this decrease was associated with the upregulation of presynaptic D2-like receptors. A D2-like receptor antagonist infused into the NAcSh reversed the decrease in PWT in rats with cast immobilization, whereas a D2-like receptor agonist infused into the NAcSh induced a decrease in PWT in control rats. In addition, the expression of the D2 receptor (Drd2) mRNA in the NAcSh was increased by cast immobilization. Importantly, systemic administration of the D2-like receptor antagonist reversed the decrease in PWT in rats with cast immobilization. As dopamine levels regulated by presynaptic D2-like receptors did not correlate with the PWT, it is presumed that the D2-like receptor antagonist or agonist acts on postsynaptic D2-like receptors. These results suggest that immobilization-induced mechanical hypersensitivity is attributable to the upregulation of postsynaptic D2-like receptors in the NAc. Blockade of D2-like receptors in the NAcSh is a potential therapeutic strategy for immobilization-induced hypersensitivity.
- Open Access
- 30 March 2016
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 19 (8) , pyw026
Long-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1AReceptors
Background: Cortical dopamine (DA) and noradrenaline (NA) are involved in the stress response. Citalopram, a selective serotonin reuptake inhibitor (SSRI), has direct and indirect effects on the serotonergic system. Furthermore, long-term treatment with citalopram affects the DA and NA systems, which could contribute to the therapeutic action of antidepressants. Methods: The effects of long-term treatment with citalopram on the responses of the DA and NA systems in the rat prefrontal cortex (PFC) to acute handling stress were evaluated using in vivo microdialysis. Results: Acute handling stress increased DA and NA levels in the PFC. The DA and NA responses were suppressed by local infusion of a 5-HT1A receptor agonist, 8-OH-DPAT, into the PFC. The DA response was abolished by long-term treatment with citalopram, and the abolished DA response was reversed by local infusion of a 5-HT1A receptor antagonist, WAY-100,635, into the PFC. On the other hand, long-term treatment with citalopram reduced the basal NA levels (to ~40% of the controls), but not the basal DA levels. The NA response was maintained despite the low basal NA levels. Signaling from the 5-HT1A receptors and α2-adrenoceptors was not involved in the decrease in the basal NA levels, but partially affected the NA response. Conclusions: Chronic citalopram treatment differentially suppresses the DA and NA systems in the PFC, and the DA stress response was preferentially controlled by up-regulating 5-HT1A receptor signaling. Our findings provide insight into how antidepressants modulate the DA and NA systems to overcome acute stress.
- 30 March 2016
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 19 (8) , pyw026
Open AccessLong-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1AReceptors
Background: Cortical dopamine (DA) and noradrenaline (NA) are involved in the stress response. Citalopram, a selective serotonin reuptake inhibitor (SSRI), has direct and indirect effects on the serotonergic system. Furthermore, long-term treatment with citalopram affects the DA and NA systems, which could contribute to the therapeutic action of antidepressants. Methods: The effects of long-term treatment with citalopram on the responses of the DA and NA systems in the rat prefrontal cortex (PFC) to acute handling stress were evaluated using in vivo microdialysis. Results: Acute handling stress increased DA and NA levels in the PFC. The DA and NA responses were suppressed by local infusion of a 5-HT1A receptor agonist, 8-OH-DPAT, into the PFC. The DA response was abolished by long-term treatment with citalopram, and the abolished DA response was reversed by local infusion of a 5-HT1A receptor antagonist, WAY-100,635, into the PFC. On the other hand, long-term treatment with citalopram reduced the basal NA levels (to ~40% of the controls), but not the basal DA levels. The NA response was maintained despite the low basal NA levels. Signaling from the 5-HT1A receptors and α2-adrenoceptors was not involved in the decrease in the basal NA levels, but partially affected the NA response. Conclusions: Chronic citalopram treatment differentially suppresses the DA and NA systems in the PFC, and the DA stress response was preferentially controlled by up-regulating 5-HT1A receptor signaling. Our findings provide insight into how antidepressants modulate the DA and NA systems to overcome acute stress.
- 1 April 2013
- Published by Elsevier in Neuropharmacology
- Vol. 67, 395-402
Food reward-sensitive interaction of ghrelin and opioid receptor pathways in mesolimbic dopamine system
- 1 April 2013
- Published by Elsevier in Neuropharmacology
- Vol. 67, 395-402
Food reward-sensitive interaction of ghrelin and opioid receptor pathways in mesolimbic dopamine system